Kopran Limited has informed the Exchange regarding Appointment of as Non- Executive Independent Director in its Subsidiary company w.e.f. May 18, 2026.
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kopran Limited's subsidiary, Kopran Research Laboratories Limited (KRLL), has appointed Mr. Chandresh Gandhi as Additional Director (Non-Executive, Independent Category) for a term of 5 years starting May 18, 2026. Mr. Gandhi is already an Independent Director on the parent company board. Additionally, KRLL will issue rights shares in the ratio of 1:12 (one share for every 12 held) at a face value of Rs 10 with a premium of Rs 90 per share, raising Rs 18.75 crore for working capital requirements.
This appointment brings experienced financial and audit expertise to the subsidiary's board. The rights issue will strengthen the subsidiary's balance sheet and support its working capital needs, which could benefit Kopran Limited's consolidated financials.